Hem › Myelodysplastiska syndrom › Wisconsin
Kliniska studier för Myelodysplastiska syndrom i Wisconsin
11 studier för Myelodysplastiska syndrom söker deltagare vid platser i Wisconsin.
Städer i Wisconsin
Officiell studietext (engelska)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Duluth Clinic Ashland, Ashland
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
- och 5 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06577441MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- och 41 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Medical College of Wisconsin, Milwaukee
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT05320198A Study of BGB-11417 in Participants With Myeloid Malignancies
- Medical College of Wisconsin, Milwaukee
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT04771130The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Medical College of Wisconsin, Milwaukee
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT06656494A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Froedtert & Medical College of Wisconsin, Milwaukee
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 apr. 2026 · NCT04256317Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 3 apr. 2026 · NCT06502145SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- University of Wisconsin Carbone Cancer Center, Madison
RekryterarFas 1
7 Months – 21 Years · Alla kön · Uppdaterad 16 okt. 2025 · NCT02508038A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- University of Wisconsin Clinical Science Center, Madison
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2025 · NCT06501196Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.